Supernus to Present at Three November Healthcare Conferences
November 07 2016 - 1:30PM
Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN), a specialty
pharmaceutical company focused on developing and commercializing
products for the treatment of central nervous system diseases,
today announced that the Company's management will present an
overview and update of the Company and host investor meetings at
the following three conferences:
Stifel 2016 Healthcare Conference Date: Tuesday, November 15,
2016 Time: 10:15 a.m. EST Place: Lotte New York Palace Hotel, New
York
Jefferies London Healthcare Conference Date: Thursday, November
17, 2016 Time: 3:20 p.m. GMT (10:20 p.m. EST) Place: Waldorf
Hilton, London, U.K.
Piper Jaffray 28th Annual Healthcare Conference Date: Tuesday,
November 29, 2016 Time: 9:00 p.m. EST Place: Lotte New York Palace
Hotel, New York
Investors interested in arranging a meeting with the Company's
management during these conferences should contact the conference
coordinator.
A live webcast of the presentations can be accessed by visiting
‘Events & Presentations’ in the Investors Section on the
Company's website at www.supernus.com. An archived replay of these
webcasts will be available for 60 days on the Company's website
after each conference.
About Supernus Pharmaceuticals, Inc.
Supernus Pharmaceuticals, Inc. is a specialty pharmaceutical
company focused on developing and commercializing products for the
treatment of central nervous system diseases. The Company has two
marketed products for epilepsy, Oxtellar XR® (extended-release
oxcarbazepine) and Trokendi XR® (extended-release topiramate). The
Company is also developing several product candidates to address
large market opportunities in psychiatry, including SPN-810 for the
treatment of Impulsive Aggression in patients with ADHD and SPN-812
for the treatment of ADHD.
CONTACT:
Jack A. Khattar, President and CEO
Gregory S. Patrick, Vice President and CFO
Supernus Pharmaceuticals, Inc.
Tel: (301) 838-2591
Or
Investor Contact:
Peter Vozzo
Westwicke Partners
Office: (443) 213-0505
Mobile: (443) 377-4767
Email: peter.vozzo@westwicke.com
Supernus Pharmaceuticals (NASDAQ:SUPN)
Historical Stock Chart
From Mar 2024 to Apr 2024
Supernus Pharmaceuticals (NASDAQ:SUPN)
Historical Stock Chart
From Apr 2023 to Apr 2024